Western cluster continues to dominate India's biotech industry with 46
percent share in the overall revenues of Rs 14,199 crore. The 137
companies in the region between themselves clocked Rs 6,631 crore in FY
2009-10 increasing the region's share in the overall revenues by 3
percent over FY 2008-09, thus gaining a lead of 6 percent over South,
its close competitor for the top slot.
Not just that, this year, Mumbai outpaced
Bangalore to become India's
Top Biotech City with a small margin of about Rs 200 crore in terms of
revenue. Besides, Gujarat's share in the total revenue has grown by
almost 50 percent as compared to its revenues of Rs 755 crore in
2008-09. In Maharashtra , Pune's contribution went down as the leading
company of the region Serum Institute of India suffered contract set
So, has South region's position vis-a-via West worsened since last
year? Not really. Given the policy and infrastructure push the
situation next year could even see a dramatic shift. South continues to
remain India's largest Biotech cluster in terms of the number of
companies. In 2009-10, it added another 9 companies-highest in the
country. The region has 172 biotech companies (West has 137 companies),
which churned out Rs 5537.68 crore in revenues in FY 2009-10 making up
39 percent of the overall revenues.
In the South region, Karnataka state government has proposed to set up
five new biotech parks and has invested Rs 1,100 crore towards
new initiatives in 2009-10. Another biotech hub Andhra Pradesh is also
setting up a MedTech Valley, a world-class cluster for manufacturing
medical devices and equipment near Genome Valley at Shameerpet in
Hyderabad. The state government will provide 1,200 acres of land for
the project. The project will be executed via a public-private
Kerala has also taken steps to jump on the biotech bandwagon. Kerala
State Industrial Development Corp (KSIDC) has announced that it will
set up a state-of-the-art life science park at Thiruvananthapuram at an
estimated cost of Rs 300 crore. The project that will come up in
260 acres at Thonnakkal, would be developed under public-private
partnership model. The park will house an incubation center, a
technology development center, biotechnology companies, drug discovery
companies, pure play firms and also contract research outsourcing units.
Looking ahead, year 2010-15 will see some shifts, specializations and
emergence of clear patterns. During this period many of the mega
initiatives are likely to take off and have the potential to be a “leap
of sorts” that can build a virtuous cycle for the region.
NCR at No 4
The Northern biocluster – National Capital Region (NCR) has the Top 3
companies contributing 56 percent of the revenues and about 15 percent
of the overall industry revenue. This cluster is better known for
its research institutes and of course, government bodies.
More recently, the development of 200 acre Health Biotech Science
Cluster (HBSC) at Faridabad is underway. A multidisciplinary approach
to education and research, this Biotech cluster would comprise
Translational Health Science & Technology Institute (THSTI),
Regional Center for Biotechnology (RCB) Center for Vaccinology,
Molecular Medicine Center, Center for Diagnostics, Biotech Park,),
Center for Health Science Technology, Center for Platform Technologies,
UNESCO Center, Incubator and a Center for Animal Model for Clinical
Advances. As a first step, a temporary THSTI lab was recently
inaugurated at Gurgaon. This would be shifted to the main site at
Faridabad in two-three years after the infrastructure is ready.
Besides, there is the biotech park at Lucknow offering a very good
platform for the small and medium biotech companies to do research,
collaborate and expand their business. The Biotech Parks at three
locations -Sitapura-Jaipur and Chopanki, Bhiwadi (Alwar), and Borandi,
Rajasthan have been initiated by Rajasthan State industrial Development
& Investment Corporation (RIICO). Then, there is the proposed
biocluster at Mohali (Punjab), upcoming biotech park at Chandigarh
(Punjab) and another one at Nalagarh in Himachal Pradesh- all
this is expected to provide the much needed boost to the biotech
companies in the North region.
Cluster Trend (2002-10)
• Top 10 companies in the West have 43% share in the region.
• Serum Institute of India (Rs 850 crore), the region's No 1 company
makes up for about 13% of the region's revenue and contributes 6%
to the overall industry revenue.
• West is also base for top bioagri companies such as Monsanto,
Mahyco and Ajeet Seeds.
• MNCs like GlaxoSmithKline, Roche, Aventis Pharma, Wyeth, Quintiles
are also headquartered in the region.
• Four of India's top 10 services companies (CROs) are also based out
of West, including the No 1 CRO in the Indian industry – Quintiles
India (Rs 375 crore)
in Rs Cr)
|Serum Institute of India*
|Reliance Life Sciences*
|Top 10 West
in Rs Cr)
|Novozymes South Asia
|Top 10 South
(Revenue in Rs Cr)
of Total Biotech
|Top 3 North
All figures in Rs. Crore
unless indicated otherwise